TCMP
EXEL icon

Thrive Capital Management (Pennsylvania)’s Exelixis EXEL Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.77M Sell
87,664
-1,077
-1% -$52.4K 0.9% 38
2026
Q1 		$3.81M Buy
88,741
+7,909
+10% +$340K 0.83% 53
2025
Q4 		$3.54M Buy
80,832
+19,155
+31% +$792K 0.79% 62
2025
Q3 		$2.55M Buy
+61,677
New +$2.48M 0.66% 62

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Thrive Capital Management (Pennsylvania)'s EXEL Position: Q2 2026 in Review

Thrive Capital Management (Pennsylvania) reduced its Exelixis (EXEL) stake by 1.2% in Q2 2026, selling an estimated $52.4K and leaving 87,664 shares worth $4.77M. The position accounts for 0.9% of the portfolio, ranked #38.

Thrive Capital Management (Pennsylvania) first reported a position in EXEL in Q3 2025 and has held it in 4 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Thrive Capital Management (Pennsylvania) held 87,664 shares of Exelixis worth $4.77M as of Q2 2026.
  • Thrive Capital Management (Pennsylvania) sold 1,077 Exelixis shares in Q2 2026, an estimated $52.4K.
  • Exelixis made up 0.9% of Thrive Capital Management (Pennsylvania)'s portfolio in Q2 2026, its #38 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Exelixis in Q3 2025 and has held it in 4 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2026, filed 5 Aug 2026.